Final Overall Survival Analysis of S1500: A Randomized, Phase II Study Comparing Sunitinib with Cabozantinib, Crizotinib, and Savolitinib in Advanced Papillary Renal Cell CarcinomaPedro Barata,Catherine Tangen,Melissa Plets,Ian M. Thompson Jr,Vivek Narayan,Daniel J. George,Daniel Y. C. Heng,Brian Shuch,Mark Stein,Shuchi Gulati,Maria Tretiakova,Abhishek Tripathi,Georg A. Bjarnason,Peter Humphrey,Adebowale Adeniran,Ulka Vaishampayan,Ajjai Alva,Tian Zhang, Scott Cole,Primo N. Lara,Seth P. Lerner,Naomi Balzer-Haas,Sumanta K. PalJOURNAL OF CLINICAL ONCOLOGY（2024）引用 1|浏览9AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
